It also had a significant lower mutation frequencies in TP53, (86.4 vs. 25.9%, P < 0.001) and LRP1B (35.3 vs. 7.4%, P = 0.002) than lung squamous cell carcinoma. This evidence concerns the gene LRP1B and squamous cell lung carcinoma.